|
⚲
|
| Keyboard |
| Versant Development Fund III LP
✚
|
|
|---|---|
| CIK # | 0001597416 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001597416] | |
| 4 | [0001597416] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Flexion Therapeutics Inc FLXN
Common Stock
|
2016-06-08 | Buy | 4,194 | $14.00 | 58,716 |
|
Flexion Therapeutics Inc FLXN
Common Stock
|
2016-06-08 | Buy | 710,091 | $14.00 | 9,941,274 |
|
Flexion Therapeutics Inc FLXN
Stock Option (right to buy) · derivative
|
2014-09-10 | Option exercise | 2,250 | $0.00 | |
|
Flexion Therapeutics Inc FLXN
Common Stock
|
2014-09-10 | Option exercise | 2,250 | $17.61 | 39,622 |
|
Flexion Therapeutics Inc FLXN
Common Stock
|
2014-02-18 | Conversion | 2,036,697 | ||
|
Flexion Therapeutics Inc FLXN
Common Stock
|
2014-02-18 | Conversion | 12,029 | ||
|
Flexion Therapeutics Inc FLXN
Common Stock
|
2014-02-18 | Buy | 1,806 | $13.00 | 23,478 |
|
Flexion Therapeutics Inc FLXN
Common Stock
|
2014-02-18 | Conversion | 385,629 | ||
|
Flexion Therapeutics Inc FLXN
Common Stock
|
2014-02-18 | Conversion | 2,277 | ||
|
Flexion Therapeutics Inc FLXN
Series A Preferred Stock · derivative
|
2014-02-18 | Conversion | 16,558,351 | $0.00 | |
|
Flexion Therapeutics Inc FLXN
Series A Preferred Stock · derivative
|
2014-02-18 | Conversion | 97,797 | $0.00 | |
|
Flexion Therapeutics Inc FLXN
Series A Preferred Stock · derivative
|
2014-02-18 | Conversion | 2,900,000 | $0.00 | |
|
Flexion Therapeutics Inc FLXN
Series B Preferred Stock · derivative
|
2014-02-18 | Conversion | 3,135,165 | $0.00 | |
|
Flexion Therapeutics Inc FLXN
Series B Preferred Stock · derivative
|
2014-02-18 | Conversion | 18,512 | $0.00 | |
|
Flexion Therapeutics Inc FLXN
Common Stock
|
2014-02-18 | Conversion | 356,703 | ||
|
Flexion Therapeutics Inc FLXN
Common Stock
|
2014-02-18 | Buy | 305,886 | $13.00 | 3,976,518 |